DK4387A - Human-praepo-insulinlignende-vaekstfaktor i samt gener og syntetiske dna-sekvenser, som koder for denne - Google Patents

Human-praepo-insulinlignende-vaekstfaktor i samt gener og syntetiske dna-sekvenser, som koder for denne

Info

Publication number
DK4387A
DK4387A DK004387A DK4387A DK4387A DK 4387 A DK4387 A DK 4387A DK 004387 A DK004387 A DK 004387A DK 4387 A DK4387 A DK 4387A DK 4387 A DK4387 A DK 4387A
Authority
DK
Denmark
Prior art keywords
praepo
insulin
genes
human
growth factor
Prior art date
Application number
DK004387A
Other languages
English (en)
Other versions
DK4387D0 (da
Inventor
Gwen Grabowski Krivi
Peter Scott Rotwein
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of DK4387D0 publication Critical patent/DK4387D0/da
Publication of DK4387A publication Critical patent/DK4387A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK004387A 1986-01-07 1987-01-06 Human-praepo-insulinlignende-vaekstfaktor i samt gener og syntetiske dna-sekvenser, som koder for denne DK4387A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81666286A 1986-01-07 1986-01-07
US06/929,671 US4963665A (en) 1986-01-07 1986-11-20 Human preproinsulin-like growth factor I

Publications (2)

Publication Number Publication Date
DK4387D0 DK4387D0 (da) 1987-01-06
DK4387A true DK4387A (da) 1987-09-18

Family

ID=27124101

Family Applications (1)

Application Number Title Priority Date Filing Date
DK004387A DK4387A (da) 1986-01-07 1987-01-06 Human-praepo-insulinlignende-vaekstfaktor i samt gener og syntetiske dna-sekvenser, som koder for denne

Country Status (12)

Country Link
US (1) US4963665A (da)
EP (1) EP0229750B1 (da)
JP (1) JPH0819158B2 (da)
KR (1) KR920005918B1 (da)
AR (1) AR246765A1 (da)
AU (1) AU588072B2 (da)
CA (1) CA1340455C (da)
DE (1) DE3789559T2 (da)
DK (1) DK4387A (da)
ES (1) ES2062993T3 (da)
IL (1) IL81175A (da)
NZ (1) NZ218811A (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070075A (en) * 1986-01-07 1991-12-03 Washington University Human preproinsulin-like growth factor I
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
US4876242A (en) * 1987-09-21 1989-10-24 Merck & Co., Inc. Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
SE9002731D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product comprising growth factor
US5612198A (en) * 1990-09-04 1997-03-18 The Salk Institute Production of insulin-like growth factor-1 in methylotrophic yeast cells
US5231178A (en) * 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
SE9201573D0 (sv) * 1992-05-19 1992-05-19 Kabi Pharmacia Ab Use of igf-1
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US5521086A (en) * 1993-09-16 1996-05-28 Cephalon, Inc. Secretion sequence for the production of a heterologous protein in yeast
SE9402370D0 (sv) 1994-07-04 1994-07-04 Pharmacia Ab Use of IGF-I
WO1996007744A1 (en) * 1994-09-08 1996-03-14 Chiron Corporation A method of improved production of insulin-like growth factor
US6030613A (en) 1995-01-17 2000-02-29 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
GB9605124D0 (en) * 1996-03-11 1996-05-08 Royal Free Hosp School Med Method of treating muscular disorders
US7741536B2 (en) 1997-08-07 2010-06-22 University Of Central Florida Research Foundation, Inc. Expression of human serum albumin in plastids
US20030204864A1 (en) * 2001-02-28 2003-10-30 Henry Daniell Pharmaceutical proteins, human therapeutics, human serum albumin, insulin, native cholera toxic b submitted on transgenic plastids
US20100251425A9 (en) 1998-05-15 2010-09-30 University Of Central Florida Expression of human interferon in transgenic chloroplasts
EP1274846A4 (en) * 2000-03-01 2004-09-29 Univ Auburn PLASTIDE TRANSFORMATION VECTOR FOR THE EXPRESSION OF HUMAN PROTEINS IN PLANTS
EP1383793B1 (en) * 2000-03-29 2011-10-19 DGI BioTechnologies, L.L.C. Insulin and igf-1 receptor agonists and antagonists
GB0011278D0 (en) 2000-05-10 2000-06-28 Univ London Repair of nerve damage
US7326417B2 (en) 2001-09-11 2008-02-05 Merial Ltd. IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses
FR2829498B1 (fr) * 2001-09-11 2003-11-28 Merial Sas Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
GB0202906D0 (en) 2002-02-07 2002-03-27 Univ London Prevention of myocardial damage
RU2372941C2 (ru) * 2007-07-02 2009-11-20 Духовлинов Илья Владимирович Фармацевтическая композиция для генной терапии заболеваний, требующих стимуляции регенераторных процессов, включая повреждения тканей человека различной этиологии, на основе синтетического модифицированного гена инсулиноподобного фактора роста человека первого типа (ифр-1, igf-1)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
EP0189481B1 (en) * 1984-07-13 1991-01-23 Chiron Corporation Insulin-like growth factor ii
AU598205B2 (en) * 1985-08-22 1990-06-21 Gropep Pty Ltd Peptide analogues of mammalian insulin-like growth factor-1
US4783524A (en) * 1985-09-17 1988-11-08 Monsanto Company Growth factors
ES2007309T3 (es) * 1987-04-23 1994-11-01 Monsanto Co Secrecion del factor de crecimiento insulinoide 1 en e.coli.

Also Published As

Publication number Publication date
AU6715187A (en) 1987-07-09
JPH0819158B2 (ja) 1996-02-28
CA1340455C (en) 1999-03-23
AR246765A1 (es) 1994-09-30
KR920005918B1 (ko) 1992-07-24
EP0229750A2 (en) 1987-07-22
US4963665A (en) 1990-10-16
DE3789559D1 (de) 1994-05-19
NZ218811A (en) 1991-07-26
DK4387D0 (da) 1987-01-06
ES2062993T3 (es) 1995-01-01
AU588072B2 (en) 1989-09-07
JPS62228285A (ja) 1987-10-07
IL81175A0 (en) 1987-08-31
EP0229750B1 (en) 1994-04-13
EP0229750A3 (en) 1989-10-25
DE3789559T2 (de) 1994-10-13
IL81175A (en) 1994-08-26
KR880006362A (ko) 1988-07-22

Similar Documents

Publication Publication Date Title
DK4387D0 (da) Human-praepo-insulinlignende-vaerkstfaktor i samt gener og syntetiske dna-sekvenser, som koder for denne
NO891818D0 (no) T4-reseptor-protein, relaterte dna-sekvenser samt fremstilling derav.
ES554046A0 (es) Un metodo para analizar el adn de un individuo.
NO893054D0 (no) Fremgangsmaate for utdypning av nukleotidsekvenser.
DE69333718D1 (de) Gen, das für eine Fisch-Transglutaminase kodiert
NO872075L (no) Herbicid-toleranse-kodende dna.
DE68924227D1 (de) DNA-Fragment.
DK38989D0 (da) Dna-sekvens
DE3886411D1 (de) Synthetisches gen.
NO872174D0 (no) Polypetidpreparater med oekt biologisk tilgjengelighet.
FI883257A7 (fi) Uudet peptidit.
IT8719810A0 (it) Metodo per il trasporto di scaglie di gomma sintetica.
NO871038D0 (no) Dna-fragment.
FI902803A7 (fi) DNA-sekvenssi, joka koodaa a-amylaasi-pullulanaasientsyymiä
FI862637A0 (fi) Steroido/3,2-c/pyrazoler anvaendbara som antiandrogena medel samt deras framstaellning.
FI891308A7 (fi) Uudet polypeptidit, joilla on kasvutekijäaktiivisuutta sekä polypeptideitä koodittavat nukleiinihapposekvenssit
DE69012109D1 (de) Dns-sequenzierung mit verwendung von chemolumineszenz.
FI901764A0 (fi) Syntetisk dna-sekvens, som kodar human insulinlik vaextfaktor ii.
DE3777723D1 (de) Nukleotidsequenz eines gens, das von einem insulinom exprimiert wird, und das davon kodierte protein.
FI862734A7 (fi) Uudet polypeptidit, joilla on kasvutekijäaktiivisuutta ja nukleiinihap posekvenssit, jotka koodaavat polypeptidejä.
GB8627123D0 (en) Dna sequence
DK578189D0 (da) Dna-sekvens
DK727688D0 (da) Malariaspecifikke dna-sekvenser, deres expressionsprodukter samt anvendelsen heraf
FI873674L (fi) --2-plasmin-inhibitorliknande protein kodande dna.
NO901587L (no) Syntetisk dna-sekvens som koder for humaninsulinlignende vekstfaktor ii.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment